Insurers are rapidly automating claims processing with artificial intelligence to boost efficiency – but experts warn this “AI arms race” is driving denial rates sharply higher. Recent data show denials climbing nationwide (16% increase from 2018 to 2024). For example, one analysis found UnitedHealthcare’s post-acute care prior-authorization denial rate jumped from ~11% in 2020 to 22.7% in 2022 as AI-driven approvals ramped up. Meanwhile state reports note hospitals facing ~23–25% denial of inpatient claims (2022–23). In short, as insurers chase faster claims reviews, automated systems often flag complex cases as denials more often than skilled human reviewers. Stanford researchers caution that opaque AI decisions without human oversight can “lead to wrongful care denials” by reinforcing existing flaws in prior-authorization processes.
Rising Denials and Financial Strain. Alongside AI expansion, denial rates have surged across health plans, hitting providers and patients hard. A recent Senate report on Medicare Advantage found two insurers denying post-acute care authorizations at 3× their normal rates by 2022. Industry experts note that 20% of Marketplace claims were denied in 2023, often with little explanation. These denials translate to higher out-of-pocket costs and delayed care. For instance, a Washington state Medicare pilot found patients waiting 2–4 times longer (about 4–8 weeks) for prescribed procedures – only to face “A.I. being used as a denial device” without clear reasons. Hospitals report patients in pain switching to more costly or risky treatments when AI delays approvals. In sum, higher “healthcare claim denial trends” are feeding a growing medical debt crisis and forcing providers into endless appeals.
Patient Costs, Delays and Appeals. Denied claims often become big bills for patients. When insurers invoke AI-based denials (sometimes rejecting care 16× more often than usual), patients may postpone needed treatments for fear of uncovered expenses. This can worsen health outcomes and financial stress. Doctors and hospitals shoulder much of the fallout: they must spend hours appealing denials that AI flagged. The American Medical Association reports 61% of physicians now “are concerned that health plans’ use of AI is increasing prior authorization denials”, harming patients and driving up administrative costs. Nearly one-third of doctors say prior-authorization denials have led to serious patient harm (hospitalization, permanent impairment or worse). In other words, when claim denials spike, patients often accrue higher out-of-pocket bills, and providers scramble through costly appeals – a burden made worse by opaque AI decisions. The result is a vicious cycle: AI accelerates claim processing, but without checks it amplifies rising denial rates in healthcare and pushes costs onto vulnerable patients.
Call for Balanced AI Oversight. These trends have spurred calls from experts to balance AI efficiency with human judgment. Stanford’s Michelle Mello and colleagues urge that AI “should augment decision-making” – not replace it – to avoid wrongful denials. Likewise, the New York Hospital Association and AMA insist each denial be reviewed by a qualified clinician. Regulators are taking notice: legislative proposals and NAIC guidelines emphasize “denials must not be automated” and require human-in-the-loop review. Transparency is also needed: insurers should disclose when AI is used and allow patients to challenge algorithmic decisions. In practice, this means improving appeals processes (e.g. clear instructions, human review of denials) and auditing AI tools for fairness. As one hospital advocate warns, unchecked AI can turn claims automation “into a denial device” that hurts patients. The consensus is clear: AI can help streamline claims, but it must be paired with robust oversight and physician review to protect patient care and curb unjust denials.
Frequently Asked Questions (FAQs)
1. How can patients appeal an AI-driven claim denial?
Patients and providers should first request a detailed explanation for the denial. Then file a formal appeal with the insurer, providing additional medical records or letters of medical necessity. Many plans have ombudsman programs or external review options for disputes. While AI won’t change overnight, human-guided appeals (with expert review) remain the key to overturning wrongful denials.
2. Are any laws regulating AI in insurance claims?
Regulators are actively looking at this issue. Some states and federal guidelines now recommend “human-in-the-loop” reviews for denials. For example, recent proposals would require insurers to disclose when AI is used and ensure licensed clinicians sign off on denials. Patients are also protected by general healthcare laws (like the ACA) that guarantee appeal rights and timely decisions.
3. Can AI ever improve claim processing positively?
Yes. Whenproperly designed and audited, AI can flag clear errors, detect fraud, and speed up routine approvals. The goal is using AI to handle simple tasks (like checking for missing info) while reserving complex medical decisions for humans. Many experts emphasize “augmented intelligence” – combining AI speed with clinician insight – to improve accuracy without harming patients.
4. Why are claims being denied more often now?
Denials have been rising due to multiple factors: tighter insurer rules, more complex treatments, and indeed more automation. Studies link much of the increase to cost-containment efforts (e.g. stricter formularies, prior auth rules) coupled with AI systems that err on the side of rejection. The upshot is that efficiency pressures have outpaced oversight, so quality checks haven’t kept up with volume.
